Literature comparison. by Saravanan Manoharan (21273304)

Subjects:

Validation of punch with timestamp: (a) Jab (b) Hook (c) Uppercut. by Saravanan Manoharan (21273304)

Subjects:

Flow chart of proposed system. by Saravanan Manoharan (21273304)

Subjects:

IMU raw data: (a) 3-DoF accelerometer data (b) 3-DoF gyroscope data. by Saravanan Manoharan (21273304)

Subjects:

Model testing results across different boxers with 15% of training dataset. by Saravanan Manoharan (21273304)

Subjects:

Expert annotation of uncertain instances to refine model training. by Saravanan Manoharan (21273304)

Subjects:

Literature review. by Saravanan Manoharan (21273304)

Subjects:

IMU data and video synchronization. by Saravanan Manoharan (21273304)

Subjects:

Punch types and its kinematics: (a) No punch (b) Long-range rear jab to head (c) Mid-range rear hook to head (d) Mid-range rear uppercut to head. by Saravanan Manoharan (21273304)

Subjects:

Combined Confusion matrix: (a) Rear hand punch recognition (b) Lead hand punch recognition. by Saravanan Manoharan (21273304)

Subjects:

Confusion matrix-punch classification. by Saravanan Manoharan (21273304)

Subjects:

Combined Confusion matrix: (a) Rear hand punch classification (b) Lead hand punch classification. by Saravanan Manoharan (21273304)

Subjects:

Accuracy metrics with different percentage of the training dataset. by Saravanan Manoharan (21273304)

Subjects:

Diagram of the mediating model of the relationship between increased inhibition in the increase of mindfulness level and the decrease of mobile phone addiction index. by Jizhao Li (5856650)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Unconfined Compressive Strength of Improved Red Clay. by Quan Shen (37564)

Subjects:

Suggestive significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Global and national estimates of deaths due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

Subjects: